RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$5.47
+0.23 (+4.39%)
Open$5.16
Previous Close$5.24
Day High$5.48
Day Low$4.97
52W High$20.99
52W Low$3.82
Volume—
Avg Volume17.6K
Market Cap4.72M
P/E Ratio—
EPS$-45.07
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+262.3% upside
Current
$5.47
$5.47
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.00M | 1.95M | 1.64M |
| Net Income | -582,985 | -504,236 | -420,334 |
| Profit Margin | -29.1% | -25.9% | -25.6% |
| EBITDA | -690,102 | -649,673 | -530,744 |
| Free Cash Flow | -724,048 | -502,155 | -609,665 |
| Rev Growth | -0.1% | -1.2% | +14.7% |
| Debt/Equity | 1.05 | 0.94 | 0.99 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |